Your browser doesn't support javascript.
loading
Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages.
Yang, Xiaodan; Liu, Xiaosong; Li, Junjie; Zhang, Pingping; Li, Hejie; Chen, Guoqiang; Zhang, Wei; Wang, Tianfang; Frazer, Ian; Ni, Guoying.
Affiliation
  • Yang X; The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou 510080, China.
  • Liu X; The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou 510080, China.
  • Li J; Cancer Research Institute, First People's Hospital of Foshan, Foshan 528000, China.
  • Zhang P; The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou 510080, China.
  • Li H; Cancer Research Institute, First People's Hospital of Foshan, Foshan 528000, China.
  • Chen G; School of Science, Engineering and Technology, University of the Sunshine Coast, Maroochydore BC, QLD 4558, Australia.
  • Zhang W; Cancer Research Institute, First People's Hospital of Foshan, Foshan 528000, China.
  • Wang T; The First Affiliated Hospital, Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou 510080, China.
  • Frazer I; School of Science, Engineering and Technology, University of the Sunshine Coast, Maroochydore BC, QLD 4558, Australia.
  • Ni G; Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore BC, QLD 4558, Australia.
Cancers (Basel) ; 14(23)2022 Nov 24.
Article in En | MEDLINE | ID: mdl-36497272

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Country of publication: